ORIGINAL RESEARCH
Accepted on 06 Nov 2025
Effect of the National Reimbursement Drug List Negotiation Policy on utilization of negotiated Anticancer Drugs in Chinese Public Hospital: A Quasi-Natural Experiment
- 167 views
- Frontiers in Medicine
- Regulatory Science
- Research Topics
- Advancing Oncology Drug Development, Approval and Access Through Multi-Stakeholder Collaboration
Advancing Oncology Drug Development, Approval and Access Through Multi-Stakeholder Collaboration
1,893
Total downloads
13k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 26 Sep 2025
Scientific and regulatory progress in advancing paediatric oncology drug development in the EU and in the US
doi 10.3389/fmed.2025.1642279
- 1,204 views
DATA REPORT
Published on 25 Sep 2025
An analysis of FDA drug approvals for oncological hematological malignancies in relation to companion diagnostics
doi 10.3389/fonc.2025.1635491
- 2,094 views
SYSTEMATIC REVIEW
Published on 21 Aug 2025
Progress, impacts and lessons from market shaping in the past decade: a systematic review
doi 10.3389/fpubh.2025.1614471
- 1,425 views
PERSPECTIVE
Published on 02 Jul 2025
Value attribution for oncology combination regimens: going beyond frameworks to balance innovation, access, and affordability
doi 10.3389/fphar.2025.1590944
- 1,647 views
ORIGINAL RESEARCH
Published on 09 Jun 2025
Adoptive cellular immunotherapy combined with chemotherapy versus chemotherapy alone in Chinese patients with metastatic colorectal cancer: a cost-effectiveness analysis to inform drug pricing
doi 10.3389/fonc.2025.1590319
- 1,435 views
OPINION
Published on 18 Dec 2024
Personalized medicine: when the common becomes the rare
doi 10.3389/fmed.2024.1523594
- 2,394 views
Published in
Frontiers in Medicine
Regulatory Science
Participating Journals
Frontiers in Public Health
- 3.4 impact factor
- 5.5 citescore